Tara Innovations LLC

Mironova Labs, Inc., formerly known as Pharma Tech International, is a leading innovator in the discovery and development of specialty ingredient technologies. With a strong foundation in small molecule synthesis and a focus on sustainable prostaglandin PG synthesis, Mironova delivers high-impact ingredient technology to global brands across various industries. Driven by a passion for excellence in Life Science research, Mironova Labs combines creativity and a deep understanding of bioactive small molecules to develop proprietary technologies that interface uniquely with biology. Committed to environmental sustainability and manufacturing excellence, Mironova Labs is dedicated to delivering next-generation ingredient innovation for health, beauty, and vitality.Generated from the website

Vioquest Pharmaceuticals Inc. is a biotechnology company based in Monmouth Junction, NJ, focusing on the development of innovative therapeutic solutions for autoimmune diseases. With a strong emphasis on research and preclinical development, the company is advancing its pipeline of drug candidates, including PV-3212, aimed at treating multiple sclerosis and other autoimmune conditions. The company is dedicated to exploring MHC II inhibition and developing inhibitors targeting diseases such as Goodpasture's syndrome and Parkinson's. Vioquest Pharmaceuticals also provides drug discovery services supported by expert medicinal chemistry and therapeutic expertise to facilitate client-driven projects. Generated from the website

Prolong Pharmaceuticals, LLC, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for complex diseases, including ischemia, hypoxia within stroke, sickle cell disease, and cystic fibrosis. With a leadership team experienced in biotechnology and a pioneering approach to PEGylation, Prolong aims to meet critical unmet medical needs through its cutting-edge biopharma solutions. The company's flagship product, PP-007 Sanguinate, employs a novel PEGylated technology to restore homeostasis by delivering oxygen to hypoxic tissues and facilitating improved perfusion while reducing inflammation. Prolong Pharmaceuticals is committed to advancing healthcare through groundbreaking therapies targeting severe and life-threatening conditions, with a strong focus on addressing the global health issue of stroke. Generated from the website